#USA #Veeva Systems #Amgen #Pleasanton #Vault CRM

Amgen to Implement Veeva Vault CRM Globally

In a significant advancement for the biotech industry, Amgen has announced its plans to deploy Veeva Vault CRM on a global scale. This decision comes as a natural evolution of a partnership that has flourished over the past decade between the two companies. Veeva Systems, a leader in cloud-based solutions for the life sciences sector, has consistently provided innovative tools that enhance patient care and support the swift delivery of new therapies.

Scott Skellenger, Amgen's senior vice president and chief information officer, highlighted the importance of this transition: "Moving to Vault CRM will help accelerate our efforts to bring new therapies to patients globally with greater speed and agility." This sentiment reflects Amgen's ongoing commitment to overcoming hurdles in the healthcare landscape, particularly in swiftly addressing the needs of patients facing chronic and severe illnesses.

Veeva Vault CRM is designed to form a robust commercial framework that empowers Amgen to deliver innovative medicines effectively. According to Matt Farrell, president of commercial strategy at Veeva, this platform will improve Amgen's interactions with healthcare professionals (HCPs) and enhance launch performance, thereby facilitating better patient outcomes. "Vault CRM will provide the agentic commercial foundation to help Amgen deliver innovative medicines for some of the world's toughest diseases to millions of patients," he stated.

The platform also features the Agentic Call Report, a function that generates commercial evidence and identifies previously unrecognized treatment barriers. This level of detail is crucial as healthcare organizations strive to understand and engage effectively with their audiences.

About Veeva Systems

Veeva Systems stands at the forefront of delivering cloud-based industry solutions tailored for life sciences. With a broad spectrum of applications and insightful data, Veeva empowers various businesses within the pharmaceutical and biotechnology realms. The company is dedicated to innovation, product excellence, and ensuring customer success. Currently, Veeva serves over 1,500 customers, comprising some of the largest pharmaceutical corporations and emerging biotech firms alike.

As a Public Benefit Corporation, Veeva maintains a strong commitment to balancing stakeholder interests—including customers, employees, shareholders, and the broader industries it impacts. To learn more about its offerings, visit veeva.com.

The announcement of Amgen's partnership with Veeva comes during a time when the demand for efficient pharmaceutical solutions is greater than ever. Real-world applications of Veeva's technologies highlight how the integration of innovative IT systems within the biotech space can drive significant changes in patient care. With these advancements, both Amgen and Veeva are poised to lead the charge towards transforming patient treatment outcomes on a global scale.

Conclusion

As biotech firms look to the future, the integration of comprehensive CRM systems like Veeva Vault could represent a turning point in how medicines are developed, marketed, and delivered. The expectation is that Amgen will not only enhance its operational efficiency through this partnership but ultimately improve the speed and quality of care that patients receive worldwide. This collaboration is a testament to the power of technology in reshaping the landscape of healthcare and holding promise for a future where innovative therapies can reach those in need more effectively than ever before.